Volume 32, Number 2—February 2026
Research
Predictors of Fatal Outcomes among Pediatric Patients Hospitalized for Rocky Mountain Spotted Fever, Sonora, Mexico, 2004–20241
Table 4
Sociodemographic and treatment predictors of fatal outcomes among pediatric patients hospitalized for Rocky Mountain spotted fever, Sonora, Mexico, 2004–2024*
| Characteristic | β coefficient | SE | aOR (95% CI)† |
|---|---|---|---|
| Intercept | 0.13 | 0.35 | 1.14 (0.58–2.25) |
| Ethnicity‡ | 1.04 | 0.45 | 2.84 (1.15–6.90) |
| Days of in-hospital doxycycline treatment | −0.46 | 0.05 | 0.63 (0.57–0.69) |
| Days from symptom onset to doxycycline treatment | 0.17 | 0.05 | 1.19 (1.08–1.31) |
| Treatment with IV or oral doxycycline monotherapy§ | −1.71 | 0.40 | 0.18 (0.08–0.38) |
*Results of logistic multivariable analysis. aOR, adjusted odds ratio; IV, intravenous. †Accounting for all the variables included in the final model. Ten observations excluded due to missing data. ‡Referent was non-Indigenous. §Referent was no dose of doxycycline or inclusion of other antibiotics in treatment course.
1Preliminary results from this study were presented at the Southeastern Pediatric Research Conference; June 6, 2025; Atlanta, Georgia, USA; and at the American Society of Tropical Medicine and Hygiene Conference; November 10, 2025; Toronto, Ontario, Canada.
2These senior authors contributed equally to this article.